Raaj Medisafe India Board of Directors

Get the latest insights into the leadership at Raaj Medisafe India. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Arpit Bangur Managing Director
Mr. Navin Jhawar Joint Managing Director
Mrs. Krishna Jajoo Non Executive Director
Mr. Rakesh Agrawal Ind. Non-Executive Director
Mr. Ateet Agrawal Ind. Non-Executive Director
Mr. Hemant Kasliwal Ind. Non-Executive Director

Raaj Medisafe India Share price

RAAJMEDI

85.99

0.00 (0.00%)
Last updated on 20 Feb, 2026 | 16:00 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

00

Today's Low

00

52 Week Low

64.08

52 Week High

102.35

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Raaj Medisafe India FAQs

The board at Raaj Medisafe India consists of experienced professionals, including Mr. Arpit Bangur , Mr. Navin Jhawar , and others, overseeing the company’s strategic and corporate governance.

Directors at Raaj Medisafe India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Arpit Bangur is the current chairman at Raaj Medisafe India.

Executive directors at Raaj Medisafe India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Raaj Medisafe India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Raaj Medisafe India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost